Abstract:Abstract Background: Metabolic disorders are prevalent health concerns worldwide, and periodontitis, an oral inflammatory disease, has been emphasized as a risk factor. Increasing evidence has indicated the role of gut microbiota and its derived metabolites during the pathogenesis of metabolic disorders. Given that the oral and gut mucosae are physically connected, it is possible that the periodontopathic bacterium may invade and alter the gut microbiota to aggravate metabolic disorders. In this study, a periodontitis mouse model was established to evaluate metabolic disorders induced by high fat diet (HFD). Metabolic labeling and in vivo imaging were introduced to determine the intestinal translocation of periodontopathic bacterium, Porphyromonas gingivalis (P. gingivalis). Moreover, metagenome sequencing and nontargeted metabolomics analysis were applied to investigate the mechanism underlying periodontitis and metabolic disorders. Results: Our study demonstrated that periodontitis aggravated metabolic disorders induced by HFD in C57BL6/N mice. P. gingivalis, a main periodontopathic bacterium, was enriched in the feces of mice with periodontitis. Moreover, the orally administered P. gingivalis could translocate to the gastrointestinal tract alive, and elicit metabolic disorders, while administration of the pasteurized P. gingivalis had no effect. Metagenome sequencing indicated that administration altered the composition, abundance, and function of gut microbiota, in which “tryptophan metabolism pathway” demonstrated a significant difference. Nontargeted metabolomics analysis revealed indole and its derivatives were decreased with P. gingivalis administration, leading to inactivation of aryl hydrocarbon receptor (AhR) signaling. Moreover, supplementation with Ficz, an AhR agonist, alleviated periodontitis-associated metabolic disorders, in which the restoration of gut barrier function might play an important role. Conclusions: Our study illustrated that periodontitis aggravated diet-induced metabolic disorders through intestinal translocation of pathogenic bacterium P. gingivalis, which elicited gut microbiota dysfunction and decreased indole and its derivatives, leading to inactivation of AhR signaling. Supplementation of AhR agonist improved metabolic disorders by restoring AhR activity and the gut barrier function, providing a novel mechanism and treatment strategy linking periodontal disease and metabolic disorders.

Periodontitis exacerbates atherosclerosis through Fusobacterium nucleatum-promoted hepatic glycolysis and lipogenesis

Fusobacterium nucleatum Accelerates Atherosclerosis via Macrophage-Driven Aberrant Proinflammatory Response and Lipid Metabolism

The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome

The Exoprotein Gbp of Fusobacterium Nucleatum Promotes THP-1 Cell Lipid Deposition by Binding to CypA and Activating PI3K-AKT/MAPK/NF-κB Pathways

The exoprotein Gbp of Fusobacterium nucleatum promotes THP-1 cell lipid deposition by binding to CypA and activating PI3K-AKT/MAPK/NF-κB pathways.

The combination of experimental periodontitis and oral microbiota from periodontitis patients aggravates liver fibrosis in mice

Acceleration of HDL-mediated cellular cholesterol efflux alleviates periodontitis

Unveiling the oral-gut connection: chronic apical periodontitis accelerates atherosclerosis via gut microbiota dysbiosis and altered metabolites in apoE-/- Mice on a high-fat diet

Periodontitis aggravates diet-induced obesity and metabolic disorders through intestinal translocation of P. gingivalis and inactivation of the aryl hydrocarbon receptor signaling

Exosomes derived from periodontitis induce hepatic steatosis through the SCD-1/AMPK signaling pathway

Periodontal pathogen Fusobacterium nucleatum infection accelerates hepatic steatosis in high‐fat diet‐fed ApoE knockout mice by inhibiting Nrf2/Keap1 signaling

The Roles of Periodontal Bacteria in Atherosclerosis

Periodontitis salivary microbiota exacerbates nonalcoholic fatty liver disease in high-fat diet-induced obese mice

Experimental Periodontitis Deteriorated Atherosclerosis Associated With Trimethylamine N-Oxide Metabolism in Mice

Oral Pathogens Exacerbate Parkinson’s Disease by Promoting Th1 Cell Infiltration in Mice

Oral pathogens exacerbate Parkinson's disease by promoting Th1 cell infiltration in mice

Acceleration of HDL-Mediated Cholesterol Efflux Alleviates Periodontitis

Polymicrobial Oral Infection with Four Periodontal Bacteria Orchestrates a Distinct Inflammatory Response and Atherosclerosis in ApoE null Mice

[Effect of Porphyromonas Gingivalis Infection on Atherosclerosis in Apolipoprotein-E Knockout Mice].

Periodontitis exacerbates pulmonary hypertension by promoting IFNγ + T cell infiltration in mice

BMAL1-Downregulation Aggravates Porphyromonas Gingivalis-Induced Atherosclerosis by Encouraging Oxidative Stress